Fate Therapeutics, Inc. Share Price Börse Stuttgart
Stocks
F6T
US31189P1021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.596 EUR | -1.37% |
|
+0.84% | +216.27% |
| Market Cap | 35Cr 30Cr 28Cr 26Cr 49Cr 3.35TCr 50Cr 335.76Cr 131.73Cr 1.64TCr 130.91Cr 128.02Cr 5.64TCr | P/E 2026 * |
-2.76x | P/E 2027 * | -2.9x |
|---|---|---|---|---|---|
| Enterprise Value | 35Cr 30Cr 28Cr 26Cr 49Cr 3.35TCr 50Cr 335.76Cr 131.73Cr 1.64TCr 130.91Cr 128.02Cr 5.64TCr | EV / Sales 2026 * |
66.4x | EV / Sales 2027 * | 66.6x |
| Free-Float |
98.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -1.37% | ||
| Current month | +18.86% | ||
| 1 month | +44.70% | ||
| 3 months | +128.72% | ||
| 6 months | +183.10% | ||
| Current year | +211.94% |
| 1 week | 2.47 |  | 2.74 |
| 1 month | 1.57 | | 2.74 |
| 3 years | 0.61 | | 7.76 |
| 5 years | 0.61 | | 79.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bahram Valamehr
CEO | Chief Executive Officer | 49 | 01/01/2025 |
Kamal Adawi
DFI | Director of Finance/CFO | 47 | 20/10/2025 |
Jessica Francis
COO | Chief Operating Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 01/12/2011 | |
Robert Epstein
BRD | Director/Board Member | 70 | 17/03/2014 |
Michael Lee
BRD | Director/Board Member | 47 | 31/07/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | +0.84% | +166.09% | -40.40% | 35Cr | |
| +0.21% | -6.28% | +56.18% | +127.90% | 5.42TCr | |
| +6.05% | +7.79% | +62.23% | +88.46% | 5.35TCr | |
| +0.89% | -2.42% | +8.07% | +434.51% | 2.37TCr | |
| +0.37% | -4.13% | -18.56% | -16.48% | 2.28TCr | |
| +4.76% | +12.11% | +46.45% | -2.13% | 1.95TCr | |
| -2.29% | -1.92% | +35.57% | -29.14% | 1.78TCr | |
| -4.00% | -10.96% | +181.91% | +328.17% | 1.6TCr | |
| +11.20% | +14.83% | +53.94% | +742.39% | 1.54TCr | |
| -0.48% | -2.30% | +22.36% | +187.62% | 1.41TCr | |
| Average | +1.77% | -1.83% | +61.42% | +182.09% | 2.63TCr | |
| Weighted average by Cap. | +2.13% | -0.61% | +49.72% | +169.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.47L 45.85L 42.39L 39.16L 73.75L 50Cr 75.09L 5.06Cr 1.98Cr 25Cr 1.97Cr 1.93Cr 85Cr | 52.36L 45.76L 42.3L 39.08L 73.6L 50Cr 74.93L 5.04Cr 1.98Cr 25Cr 1.97Cr 1.92Cr 85Cr |
| Net income | -13Cr -12Cr -11Cr -9.9Cr -19Cr -1.27TCr -19Cr -127.8Cr -50Cr -623.91Cr -50Cr -49Cr -2.15TCr | -15Cr -13Cr -12Cr -11Cr -21Cr -1.42TCr -21Cr -142.54Cr -56Cr -695.91Cr -56Cr -54Cr -2.4TCr |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 14/26/14 | €2.596 | -1.37% |
| 13/26/13 | €2.632 | -2.95% |
| 10/26/10 | €2.712 | +0.44% |
| 09/26/09 | €2.700 | +5.22% |
| 08/26/08 | €2.566 | -2.51% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FATE Stock
- F6T Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
